SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-103184
Filing Date
2023-09-22
Accepted
2023-09-22 16:05:55
Documents
13
Period of Report
2023-09-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326755d1_8k.htm   iXBRL 8-K 26287
2 EXHIBIT 3.1 tm2326755d1_ex3-1.htm EX-3.1 17995
  Complete submission text file 0001104659-23-103184.txt   227157

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snpx-20230922.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20230922_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20230922_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2326755d1_8k_htm.xml XML 3524
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 231271760
SIC: 2834 Pharmaceutical Preparations